Published in J Am Coll Cardiol on March 01, 1999
Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging (2010) 1.49
I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study. Eur J Nucl Med Mol Imaging (2007) 1.38
Prognostic significance of cardiac (123)I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study. Heart (2001) 1.07
Variations in 123I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation. Eur J Nucl Med Mol Imaging (2007) 0.94
Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging. Heart (2007) 0.93
How to use myocardial 123I-MIBG scintigraphy in chronic heart failure. Eur J Nucl Med Mol Imaging (2009) 0.92
Impact of mediastinal, liver and lung (123)I-metaiodobenzylguanidine ( (123)I-MIBG) washout on calculated (123)I-MIBG myocardial washout. Eur J Nucl Med Mol Imaging (2009) 0.92
Impaired cardiac adrenergic innervation assessed by MIBG imaging as a predictor of treatment response in childhood dilated cardiomyopathy. Heart (2001) 0.91
Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin-converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure. Eur J Nucl Med Mol Imaging (2004) 0.87
Prognostic value of sympathetic innervation and cardiac asynchrony in dilated cardiomyopathy. Eur J Nucl Med Mol Imaging (2008) 0.82
The potential role of iodine-123 metaiodobenzylguanidine imaging for identifying sustained ventricular tachycardia in patients with cardiomyopathy. Curr Cardiol Rep (2013) 0.80
Cardiac autonomic nervous system in heart failure: imaging technique and clinical implications. Curr Cardiol Rev (2011) 0.80
Diagnostic cutoff points for ¹²³I-MIBG myocardial scintigraphy in a Caucasian population with Parkinson's disease. Eur J Nucl Med Mol Imaging (2011) 0.80
Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients? Eur J Nucl Med Mol Imaging (2008) 0.78
Will innervation imaging predict ventricular arrhythmias in ischaemic cardiomyopathy? Eur J Nucl Med Mol Imaging (2006) 0.77
Influence of myocardial region of interest definition on quantitative analysis of planar 123I-mIBG images. Eur J Nucl Med Mol Imaging (2013) 0.77
Preoperative iodine-123 meta-iodobenzylguanidine imaging is a novel predictor of left ventricular reverse remodeling during treatment with a left ventricular assist device. J Artif Organs (2015) 0.77
Radionuclide imaging of neurohormonal system of the heart. Theranostics (2015) 0.75
Effect of Nebivolol on MIBG Parameters and Exercise in Heart Failure with Normal Ejection Fraction. Arq Bras Cardiol (2016) 0.75
Orbital and millennial Antarctic climate variability over the past 800,000 years. Science (2007) 5.10
Urodynamic testing--is it a useful tool in the management of children with cutaneous stigmata of occult spinal dysraphism? J Urol (2012) 3.35
Engagement of T cell receptor triggers its recruitment to low-density detergent-insoluble membrane domains. EMBO J (1998) 2.83
Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology (2001) 2.75
Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue. A large-scale French experience. N Engl J Med (1990) 2.66
High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology (1993) 2.65
Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology (2000) 2.34
Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut (2002) 2.21
High-dose alfentanil for myocardial revascularization: a hemodynamic and pharmacokinetic study. J Cardiothorac Vasc Anesth (1991) 1.96
A non-invasively determined surrogate of cardiac power ('circulatory power') at peak exercise is a powerful prognostic factor in chronic heart failure. Eur Heart J (2002) 1.82
Relationship between alcohol and tobacco dependencies among alcoholics who smoke. Addiction (1995) 1.81
Purification and properties of sialoadhesin, a sialic acid-binding receptor of murine tissue macrophages. EMBO J (1991) 1.79
Incidence, clinical significance and prognosis of ventricular fibrillation in the early phase of myocardial infarction. Eur Heart J (1986) 1.74
Antegrade cerebral perfusion with cold blood: a 13-year experience. Ann Thorac Surg (1999) 1.73
Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French Registry. Am J Transplant (2006) 1.73
Supralesional and sublesional bone mineral density in spinal cord-injured patients. Bone (2000) 1.67
Clinical impact of (18)F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative (131)I scanning results after therapy. J Nucl Med (2001) 1.55
Simultaneous determination of serum neopterin and C-reactive protein as markers of infection in heart-transplant recipients. Clin Chem (1989) 1.52
Valve repair with Carpentier techniques. The second decade. J Thorac Cardiovasc Surg (1990) 1.49
Comparison of the prognostic value of left ventricular filling and peak oxygen uptake in patients with systolic heart failure. Eur Heart J (2000) 1.48
Correlation between decreased myocardial glucose phosphorylation and the DNA mutation size in myotonic dystrophy. Circulation (1994) 1.47
Replacement of the transverse aortic arch during emergency operations for type A acute aortic dissection. Report of 26 cases. J Thorac Cardiovasc Surg (1988) 1.47
Adenoviral SERCA1a gene transfer to adult rat ventricular myocytes induces physiological changes in calcium handling. Cardiovasc Res (2001) 1.43
Golgi retention of a trans-Golgi membrane protein, galactosyltransferase, requires cysteine and histidine residues within the membrane-anchoring domain. Proc Natl Acad Sci U S A (1992) 1.43
Nonsteroidal antiinflammatory drug-induced colitis and misoprostol. Dig Dis Sci (1996) 1.42
A monoclonal antibody against meningococcus group B polysaccharides distinguishes embryonic from adult N-CAM. J Cell Biol (1986) 1.42
Neutrophils recruit and activate human endothelial colony-forming cells at the site of vessel injury via P-selectin glycoprotein ligand-1 and L-selectin. J Thromb Haemost (2014) 1.41
Near fatal respiratory distress following massive ether intravenous injection. Intensive Care Med (1998) 1.39
Effect of systemic hypertension on renal function and left ventricular hypertrophy in heart transplant recipients. J Am Coll Cardiol (1990) 1.38
Automatic segmentation of in-vivo intra-coronary optical coherence tomography images to assess stent strut apposition and coverage. Int J Cardiovasc Imaging (2011) 1.36
A simple clinico-histopathological composite scoring system is highly predictive of graft outcomes in marginal donors. Am J Transplant (2008) 1.31
Clinical performance with the Levitronix Centrimag short-term ventricular assist device. J Heart Lung Transplant (2006) 1.30
Molecular cloning and expression of mouse and human cDNAs encoding heparan sulfate D-glucosaminyl 3-O-sulfotransferase. J Biol Chem (1997) 1.30
Aortic root replacement with a composite graft. Factors influencing immediate and long-term results. Eur J Cardiothorac Surg (1996) 1.29
Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy. Br J Cancer (2004) 1.29
Left ventricular outflow obstruction after mitral valve repair (Carpentier's technique). Proposed mechanisms of disease. Circulation (1988) 1.27
FDG-PET improves surgical outcome in negative MRI Taylor-type focal cortical dysplasias. Neurology (2010) 1.25
Left ventricular function and hyperthyroidism. Br Heart J (1981) 1.25
Induction of labor with mifepristone (RU 486) in intrauterine fetal death. Am J Obstet Gynecol (1990) 1.23
Aortic dissection. Prevalence, cause, and results of late reoperations. J Thorac Cardiovasc Surg (1994) 1.21
Prolonged kinetics of recovery of oxygen consumption after maximal graded exercise in patients with chronic heart failure. Analysis with gas exchange measurements and NMR spectroscopy. Circulation (1995) 1.18
Cold cerebroplegia. A new technique of cerebral protection during operations on the transverse aortic arch. J Thorac Cardiovasc Surg (1991) 1.18
Platelet-activating factor (PAF-acether) enhances the concomitant production of tumour necrosis factor-alpha and interleukin-1 by subsets of human monocytes. Immunology (1991) 1.16
Gentamicin, netilmicin, dibekacin, and amikacin nephrotoxicity and its relationship to tubular reabsorption in rabbits. Antimicrob Agents Chemother (1984) 1.15
Limited surgical approach for explanting the HeartMate II left ventricular assist device after myocardial recovery. J Thorac Cardiovasc Surg (2008) 1.14
The F3 neuronal glycosylphosphatidylinositol-linked molecule is localized to glycolipid-enriched membrane subdomains and interacts with L1 and fyn kinase in cerebellum. J Neurochem (1995) 1.14
Valve extension with glutaraldehyde-preserved autologous pericardium. Results in mitral valve repair. J Thorac Cardiovasc Surg (1991) 1.12
[Pleuro-pulmonary paragonimiasis]. Med Mal Infect (2005) 1.11
The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice. J Exp Med (1994) 1.10
In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A. J Exp Med (1993) 1.10
Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patient. Leukemia (1994) 1.08
Abrupt change of Antarctic moisture origin at the end of Termination II. Proc Natl Acad Sci U S A (2010) 1.04
Left ventricular-arterial coupling in systemic hypertension: analysis by means of arterial effective and left ventricular elastances. J Hypertens (1994) 1.03
Revisited role of microparticles in arterial and venous thrombosis. J Thromb Haemost (2013) 1.03
Vascular aphasias: main characteristics of patients hospitalized in acute stroke units. Stroke (2002) 1.02
[Cardiac involvement in Behçet's disease. 12 cases]. Presse Med (1988) 1.01
Non-Hodgkin's lymphoma of the heart in patients infected with human immunodeficiency virus. Clin Cardiol (1997) 1.01
Physicochemical characteristics of emulsions during fat digestion in human stomach and duodenum. Am J Physiol (1996) 1.00
04 and A007-sulfatide antibodies bind to embryonic Schwann cells prior to the appearance of galactocerebroside; regulation of the antigen by axon-Schwann cell signals and cyclic AMP. Development (1990) 1.00
Assessment and follow-up of patients with aortic regurgitation by an updated Doppler echocardiographic measurement of the regurgitant fraction in the aortic arch. Circulation (1985) 1.00
Cytokine regulation of lung fibroblast proliferation. Pulmonary and systemic changes in asbestos-induced pulmonary fibrosis. Am Rev Respir Dis (1986) 0.99
Suppressors of thermosensitive mutations in the DNA polymerase delta gene of Saccharomyces cerevisiae. Mol Gen Genet (1995) 0.99
Leukotrienes and macrophage activation: augmented cytotoxic activity and enhanced interleukin 1, tumor necrosis factor and hydrogen peroxide production. Agents Actions (1989) 0.99
Score tests for homogeneity of regression effect in the proportional hazards model. Biometrics (1989) 0.98
Structural and genetic analysis of a mutant of Rhodobacter sphaeroides WS8 deficient in hook length control. J Bacteriol (1997) 0.97
[Cardiac hemochromatosis. Anatomic, clinical and hemodynamical data]. Nouv Presse Med (1975) 0.95
Surgery of type A acute aortic dissection with Gelatine-Resorcine-Formol biological glue: a twelve-year experience. J Cardiovasc Surg (Torino) (1990) 0.95
Effects of aging on left ventricular-arterial coupling in man: assessment by means of arterial effective and left ventricular elastances. J Hum Hypertens (1996) 0.95
Myocardial viability assessment in ischemic cardiomyopathy: benefits of coronary revascularization. Ann Thorac Surg (1994) 0.95
[The threshold of synchronous response of the myocardial fibers. Application to the experimental comparison of the efficacy of different forms of electroshock defibrillation]. Arch Mal Coeur Vaiss (1967) 0.94
Diagnostic accuracy and prognostic value of combined dipyridamole-exercise thallium imaging in hemodialysis patients. Kidney Int (1998) 0.94
Interaction between pulse wave velocity, augmentation index, pulse pressure and left ventricular function in chronic heart failure. J Hum Hypertens (2006) 0.93
[Ventricular tachycardia and "volley of ventricular spikes". Morphological frontiers between ventricular dysrhythmias]. Arch Mal Coeur Vaiss (1973) 0.92
IFN-gamma prevents Th2 cell-mediated pathology after neonatal injection of semiallogenic spleen cells in mice. J Immunol (1994) 0.92
Troponin T mRNA and protein isoforms in the human left ventricle: pattern of expression in failing and control hearts. J Mol Cell Cardiol (1997) 0.92
The hook gene (flgE) is expressed from the flgBCDEF operon in Rhodobacter sphaeroides: study of an flgE mutant. J Bacteriol (2001) 0.92
Beta-adrenergic contractile reserve as a predictor of clinical outcome in patients with idiopathic dilated cardiomyopathy. Am Heart J (1992) 0.92
Prevalence and significance of left ventricular filling abnormalities determined by Doppler echocardiography in young type I (insulin-dependent) diabetic patients. Am J Cardiol (1989) 0.91
Impaired cardiac adrenergic innervation assessed by MIBG imaging as a predictor of treatment response in childhood dilated cardiomyopathy. Heart (2001) 0.91
The problem of a covariate-time qualitative interaction in a survival study. Biometrics (1991) 0.91
Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders. J Am Acad Child Adolesc Psychiatry (1992) 0.90
Evaluation of the elasticity and characteristic impedance of the ascending aorta in man. Cardiovasc Res (1978) 0.89
[Cold-induced paralysis of the phrenic nerve in open-heart surgery (author's transl)]. Nouv Presse Med (1981) 0.89
Penetration of vancomycin in uninfected sternal bone. Antimicrob Agents Chemother (1992) 0.89
Primary coronary angioplasty for acute myocardial infarction with contraindication to thrombolysis. Am J Cardiol (1993) 0.89
Characterization of emulsions and lipolysis of dietary lipids in the human stomach. Am J Physiol (1994) 0.89
Detection of explosives and their degradation products in soil environments. J Chromatogr A (2002) 0.89
Transforming growth factor-beta inhibition of insulin-like growth factor-binding protein-5 synthesis in skeletal muscle cells involves a c-Jun N-terminal kinase-dependent pathway. J Biol Chem (2001) 0.89
Interaction of FliI, a component of the flagellar export apparatus, with flagellin and hook protein. Biochim Biophys Acta (1999) 0.89
Effects of oat bran, rice bran, wheat fiber, and wheat germ on postprandial lipemia in healthy adults. Am J Clin Nutr (1992) 0.89
Study of left ventricular pressure-volume relations during nitroprusside infusion in human subjects without coronary artery disease. Br Heart J (1979) 0.88
In vivo and in vitro effects of TGF-beta 1 on normal and neoplastic haemopoiesis. Ciba Found Symp (1991) 0.88
Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study. Hepatology (1997) 0.88
Aortic input impedance in heart failure: comparison with normal subjects and its changes during vasodilator therapy. Eur Heart J (1984) 0.87
[Studies of assisted circulation. I. Methods of repetitive provoked extrasystole and slowing of effective heart rate]. Arch Mal Coeur Vaiss (1967) 0.87